Anonymous

Mental Health Act: Involuntarily Admitted Patients (14:VII): Difference between revisions

From Clicklaw Wikibooks
Line 98: Line 98:
Under s 25(2) the review panel is authorized to determine whether the detention of the patient should continue. The patient’s detention must continue if ss 22(3)(a)(ii) and (c) continue to describe the patient. That is, the patient is a person with a mental disorder who requires treatment in or through a  designated mental health facility; the patient requires care, control and supervision in or through a designated mental health facility; the patient is a threat to him or herself or others; or detention is necessary to prevent substantial deterioration of the patient’s mental or physical person and he or she is  unsuitable as a voluntary patient. A review panel hearing must be conducted notwithstanding any defects in authority for the initial or renewed detention pursuant to s 22.
Under s 25(2) the review panel is authorized to determine whether the detention of the patient should continue. The patient’s detention must continue if ss 22(3)(a)(ii) and (c) continue to describe the patient. That is, the patient is a person with a mental disorder who requires treatment in or through a  designated mental health facility; the patient requires care, control and supervision in or through a designated mental health facility; the patient is a threat to him or herself or others; or detention is necessary to prevent substantial deterioration of the patient’s mental or physical person and he or she is  unsuitable as a voluntary patient. A review panel hearing must be conducted notwithstanding any defects in authority for the initial or renewed detention pursuant to s 22.


The review panel must consider the past history of the patient, including his or her past history of compliance with treatment plans. The panel must assess  whether there is a significant risk that the patient will not comply with treatment prescribed
The review panel must consider the past history of the patient, including his or her past history of compliance with treatment plans. The panel must assess  whether there is a significant risk that the patient will not comply with treatment prescribed by the director. Presumably, if the panel concludes that there is  a significant risk that the patient will not comply with the treatment plan, it is open to them to conclude that ss 22(3)(a)(ii) and (c) continue to describe the patient (i.e. the patient may get worse if not compelled to continue treatment). Again, the MHA amendments have made the criteria for detention broader and it would seem likely that it will be more difficult for patients to end their detention under the MHA.